US FDA evaluating effectiveness of COVID-19 vaccines against Omicron
BioNTech and Pfizer's established COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant.
Signage is seen outside of FDA headquarters in White Oak, Maryland.Updated: